Active Ingredient: Medroxyprogesterone acetate 150 mg/mL.
Registration Number (MAL): MAL19872273AZ
Manufacturer: Pfizer Manufacturing Belgium NV
Active Ingredient: Medroxyprogesterone acetate 150 mg/mL.
Excipients: Includes methylparaben, propylparaben, sodium chloride, macrogol 3350, polysorbate 80, hydrochloric acid, sodium hydroxide, and water for injection.
Appearance: White, sterile, aqueous suspension.
Contraception: Long-term suppression of ovulation.
Gynecology: Treatment of endometriosis and menopausal vasomotor symptoms.
Oncology: Adjunctive and/or palliative treatment of recurrent and/or metastatic endometrial or renal carcinoma; treatment of hormonally-dependent, recurrent breast cancer in postmenopausal women.
Administration: Injectable suspension should be shaken well before use. Administer 150 mg intramuscularly every 3 months.
Injection Sites: Gluteal or deltoid muscle; not for subcutaneous use.
Contraindications: Avoid use during pregnancy and in patients with known or suspected hormone-dependent malignancies.
Malaysia
